Valsts: Īrija
Valoda: angļu
Klimata pārmaiņas: HPRA (Health Products Regulatory Authority)
SULPHADIMIDINE SODIUM BP
Eurovet Animal Health B.V.
QJ01EQ03
SULPHADIMIDINE SODIUM BP
1000 mg/g
Powder for Oral Solution
POM
Bovine, Fowl
Sulfadimidine QP51AG01 Sulfadimidine
Antibacterial
Authorised
1988-10-01
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE VETERINARY MEDICINAL PRODUCT Sulphadimidine Sodium Powder for Oral Solution 2 QUALITATIVE AND QUANTITATIVE COMPOSITION PER G POWDER: Sulphadimidine Sodium 1000 mg For a full list of excipients see section 6.1. 3 PHARMACEUTICAL FORM Powder for oral solution. A white or creamy white odourless powder 4 CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle and poultry (non-laying hens and broilers). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES For the treatment of infections caused by micro-organisms (both bacteria and coccidia) susceptible to sulphadimidine. 4.3 CONTRAINDICATIONS Do not use in animals with serious liver and renal disturbances or in animals with diseases accompanied with a decreased intake of fluids or a decreased urine production, or in cases of aciduria. Do not use in animals with damage to the haematopoietic system. Do not administer to laying hens. Do not use in cases of hypersensitivity to the active ingredient. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES After administration of this product to ruminants, sometimes a temporary interference with ruminal function and microfloral activity may occur. However, spontaneous recovery is likely. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Monitor water intake in poultry and calves during treatment. Special precautions to be taken by the person administering the veterinary medicinal product to animals Avoid skin contact with the powder and avoid inhalation of the dust. HEALTH PRODUCTS REGULATORY AUTHORITY ________________________________________________________________________________________________________________________ _Date Printed 23/12/2016_ _CRN 7025267_ _page number: 1_ 4.6 ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS) Hypersensitivity reactions may occur, but a Izlasiet visu dokumentu